{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T23:08:31Z","timestamp":1767827311369,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,6,11]],"date-time":"2016-06-11T00:00:00Z","timestamp":1465603200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s00280-016-3070-2","type":"journal-article","created":{"date-parts":[[2016,6,11]],"date-time":"2016-06-11T14:52:25Z","timestamp":1465656745000},"page":"199-207","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effects of first-line chemotherapy on natural killer cells in adult T-cell leukemia\u2013lymphoma and peripheral T-cell lymphoma"],"prefix":"10.1007","volume":"78","author":[{"given":"Michinori","family":"Ogura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Tsukasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atae","family":"Utsunomiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,11]]},"reference":[{"key":"3070_CR1","volume-title":"WHO classification of tumors of hematopoietic and lymphoid tissues","author":"The International Agency for Research on Cancer","year":"2008","unstructured":"The International Agency for Research on Cancer (2008) WHO classification of tumors of hematopoietic and lymphoid tissues, 4th edn. International Agency for Research on Cancer (IARC), Lyon","edition":"4"},{"key":"3070_CR2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","volume":"50","author":"T Uchiyama","year":"1977","unstructured":"Uchiyama T, Yodoi J, Sagawa K et al (1977) Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 50:481\u2013492","journal-title":"Blood"},{"key":"3070_CR3","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","volume":"77","author":"BJ Poiesz","year":"1980","unstructured":"Poiesz BJ, Ruscetti FW, Gazdar AF et al (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77:7415\u20137419","journal-title":"Proc Natl Acad Sci USA"},{"key":"3070_CR4","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","volume":"78","author":"Y Hinuma","year":"1981","unstructured":"Hinuma Y, Nagata K, Hanaoka M et al (1981) Adult T-cell leukemia: antigen in an ATL cell line and detection\u00a0of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 78:6476\u20136480","journal-title":"Proc Natl Acad Sci USA"},{"key":"3070_CR5","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/bjh.12659","volume":"164","author":"D Chihara","year":"2014","unstructured":"Chihara D, Ito H, Matsuda T et al (2014) Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol 164:536\u2013545","journal-title":"Br J Haematol"},{"key":"3070_CR6","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D (2008) International T-cell Lymphoma project. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26:4124\u20134130","journal-title":"J Clin Oncol"},{"key":"3070_CR7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1365-2141.2001.02737.x","volume":"113","author":"Y Yamada","year":"2001","unstructured":"Yamada Y, Tomonaga M, Fukuda H et al (2001) A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan clinical oncology group study 9303. Br J Haematol 113:375\u2013382","journal-title":"Br J Haematol"},{"key":"3070_CR8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/jjco\/hyr168","volume":"42","author":"K Tsukasaki","year":"2012","unstructured":"Tsukasaki K, Tobinai K, Hotta T et al (2012) Lymphoma study group of JCOG. Jpn J Clin Oncol 42:85\u201395","journal-title":"Jpn J Clin Oncol"},{"key":"3070_CR9","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","volume":"25","author":"K Tsukasaki","year":"2007","unstructured":"Tsukasaki K, Utsunomiya A, Fukuda H et al (2007) VCAP\u2013AMP\u2013VECP compared with biweekly CHOP for adult T-cell leukemia\u2013lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol 25:5458\u20135464","journal-title":"J Clin Oncol"},{"key":"3070_CR10","unstructured":"National Comprehensive Cancer Network (2014) NCCN Clinical practice guidelines in oncology (NCCN Guidelines\u00ae). Non-Hodgkin\u2019s lymphomas, version 2"},{"key":"3070_CR11","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1182\/blood-2003-10-3389","volume":"103","author":"G Enblad","year":"2004","unstructured":"Enblad G, Hagberg H, Erlanson M et al (2004) A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas. Blood 103:2920\u20132924","journal-title":"Blood"},{"key":"3070_CR12","first-page":"702","volume":"90","author":"PL Zinzani","year":"2005","unstructured":"Zinzani PL, Alinari L, Tani M et al (2005) Preliminary observation of a phase II study of reduced-dose alemtuzumab in patients with pretreated T-cell lymphoma. Haematologica 90:702\u2013703","journal-title":"Haematologica"},{"key":"3070_CR13","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1200\/JCO.2009.25.3575","volume":"28","author":"K Yamamoto","year":"2010","unstructured":"Yamamoto K, Utsunomiya A, Tobinai K et al (2010) Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia\u2013lymphoma and peripheral T-cell lymphoma. J Clin Oncol 28:1591\u20131598","journal-title":"J Clin Oncol"},{"key":"3070_CR14","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","volume":"30","author":"T Ishida","year":"2012","unstructured":"Ishida T, Joh T, Uike N et al (2012) Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia\u2013lymphoma: a multicenter phase II study. J Clin Oncol 30:837\u2013842","journal-title":"J Clin Oncol"},{"key":"3070_CR15","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1200\/JCO.2013.52.0924","volume":"32","author":"M Ogura","year":"2014","unstructured":"Ogura M, Ishida T, Hatake K et al (2014) Multicenter phase II study of mogamulizumab (KW-0761) a defucosylated anti-CC chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma. J Clin Oncol 32:1157\u20131163","journal-title":"J Clin Oncol"},{"key":"3070_CR16","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1200\/JCO.2011.38.0402","volume":"30","author":"B Pro","year":"2012","unstructured":"Pro B, Advani R, Brice P et al (2012) Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study. J Clin Oncol 30:2190\u20132196","journal-title":"J Clin Oncol"},{"key":"3070_CR17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier B, Lepage E, Briere J et al (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346:235\u2013242","journal-title":"N Engl J Med"},{"key":"3070_CR18","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1158\/0008-5472.CAN-03-2068","volume":"64","author":"R Niwa","year":"2004","unstructured":"Niwa R, Shoji-Hosaka E, Sakurada M et al (2004) Defucosylated chimeric anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T-cell leukemia and lymphoma. Cancer Res 64:2127\u20132133","journal-title":"Cancer Res"},{"key":"3070_CR19","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/1078-0432.CCR-09-2697","volume":"16","author":"T Ishii","year":"2010","unstructured":"Ishii T, Ishida T, Utsunomiya A et al (2010) Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia\/lymphoma. Clin Cancer Res 16:1520\u20131531","journal-title":"Clin Cancer Res"},{"key":"3070_CR20","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/bit.20151","volume":"87","author":"N Yamane-Ohnuki","year":"2004","unstructured":"Yamane-Ohnuki N, Kinoshita S, Inoue-Urakubo M et al (2004) Establishment of FUT8 knockout Chinese hamster ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity. Biotechnol Bioeng 87:614\u2013622","journal-title":"Biotechnol Bioeng"},{"key":"3070_CR21","first-page":"4768","volume":"43","author":"M Seto","year":"1983","unstructured":"Seto M, Takahashi T, Nakamura S et al (1983) In vivo antitumor effects of monoclonal antibodies with different immunoglobulin classes. Cancer Res 43:4768\u20134773","journal-title":"Cancer Res"},{"key":"3070_CR22","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","volume":"79","author":"M Shimoyama","year":"1991","unstructured":"Shimoyama M (1991) Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia lymphoma: a report from the Lymphoma Study Group (1984\u201387). Br J Haematol 79:428\u2013437","journal-title":"Br J Haematol"},{"key":"3070_CR23","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1002\/ijc.22536","volume":"120","author":"H Yano","year":"2007","unstructured":"Yano H, Ishida T, Inagaki A et al (2007) Regulatory T-cell function of adult T-cell leukemia\/lymphoma cells. Int J Cancer 120:2052\u20132057","journal-title":"Int J Cancer"},{"key":"3070_CR24","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.clim.2004.04.003","volume":"112","author":"P Trzonkowski","year":"2004","unstructured":"Trzonkowski P, Szmit E, My\u015bliwska J et al (2004) CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction. Clin Immunol 112:258\u2013267","journal-title":"Clin Immunol"},{"key":"3070_CR25","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.4049\/jimmunol.176.3.1582","volume":"176","author":"MJ Smyth","year":"2006","unstructured":"Smyth MJ, Teng MW, Swann J et al (2006) CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer. J Immunol 176:1582\u20131587","journal-title":"J Immunol"},{"key":"3070_CR26","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/bjh.13338","volume":"169","author":"T Ishida","year":"2015","unstructured":"Ishida T, Jo T, Takemoto S et al (2015) Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study. Br J Haematol 169:672\u2013682","journal-title":"Br J Haematol"},{"key":"3070_CR27","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1182\/blood-2007-02-074641","volume":"110","author":"A Gallamini","year":"2007","unstructured":"Gallamini A, Zaja F, Patti C et al (2007) Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial. Blood 110:2316\u20132323","journal-title":"Blood"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-016-3070-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-016-3070-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-016-3070-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T04:15:29Z","timestamp":1600748129000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-016-3070-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,11]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["3070"],"URL":"https:\/\/doi.org\/10.1007\/s00280-016-3070-2","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,11]]}}}